Your Source for Venture Capital and Private Equity Financings

Massinvestor/VC News Daily

VC-funded Company:

Apexigen
863 Mitten Road, Suite 103
Burlingame, CA 94010
Phone: 650-931-6236
www.apexigen.com

Apexigen is a biopharmaceutical product development company advancing a pipeline of novel product candidates with the potential to address life-threatening and difficult to treat diseases. The company's proprietary technology platform enables the discovery and development of superior antibody product candidates that are able to impact previously inaccessible disease targets. Apexigen is actively pursuing product development, both by itself and in collaboration with partners. The company's product portfolio is comprised of humanized antibodies, targeting diseases such as cancer, inflammatory diseases and ophthalmic disease. Apexigen's technology platform and product pipeline have been validated by a number of partnerships representing both product development and antibody technology collaborations.

Key Contact
Name
Xiaodong Yang
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
08/06/13 $20,000,000 Series A-1 Amkey Ventures
Sycamore Ventures
Themes Investment Partners
WSR Capital
08/09/18 $73,000,000 Venture 3E Bioventures
Decheng Capital
SV Tech Ventures
Virtus Inspire Ventures
03/24/20 $65,000,000 Series C Extension Decheng Capital
Oceanpine Capital